JOHN ADAMS: Open Payments
NPI 1639109739 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 13 payments from 9 companies in 2025. Trend: 2023 $594 · 2024 $1,098 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 4 | $90 |
| Nalu Medical, Inc. | 1 | $47 |
| Globus Medical, Inc. | 2 | $36 |
| Bioventus LLC | 1 | $32 |
| Astellas Pharma US Inc | 1 | $30 |
| Boston Scientific Corporation | 1 | $27 |
| Abbott Laboratories | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Curonix LLC | 1 | $14 |
Products named: Belbuca, Nalu Neurostimulation System, Senza, GELSYN-3, Xtandi, General - Therapies, PROCLAIM, RELISTOR.
Industry payments across FL — which companies pay providers there.
